What’s stopping psychedelic therapy in China? 5 Questions with medical ethicist Jennifer Docherty
Docherty discusses her interviews about psychedelic end-of-life care with clinicians in Hong Kong.
External link. We are not responsible for the content.
Read more ↗More From The Microdose (Berkeley)
What is an “embedded” brain? Johnson & Johnson plans to invest in “neuroplastogen” company Delix; and University of Miami gifts Trump Administration accelerated path to research ibogaine
Plus: Oregon psilocybin program “generally safe,” according to new study, and New Mexico begins accepting psilocybin ...
What’s the difference between recreational and therapeutic psychedelic use? 5 Questions with experimental psychologist Harriet de Wit
De Wit discusses the difficulty of finding out what a drug does, outside of its context.
Veterans Affairs continues to drive federal psychedelics push; New FDA guidance; and Resilient Pharmaceuticals tries again for MDMA approval
Plus: Pharmaceutical giant Eli Lilly makes a psychedelics acquisition; Cardiovascular safety is top of mind for psych...
Latest News
University of Miami’s Gift of 1994 Ibogaine IND to HHS Sets a Standard for Open Science
Washington, D.C., August 25, 2026 — The Multidisciplinary Association for Psychedelic Studies (MAPS)has welcomed the ...
MDMA and the FDA, Take Two
PLUS the Psychedelic Seeker's Guide, the World Ayahuasca Forum, and the best films to get trippy to. [...] Read More....
Global Altered States: Anytown, USA
This Week's Sunday Insider, Global Altered States: The Psychedelic Revolution is smaller than it looks.
Psychedelic Policy Briefing 8.21.26
Resilient Pharmaceuticals (formerly Lykos Therapeutics and MAPS PBC), reportedly resubmitted their once-rejected New ...
5 Psychedelic Stories You Should Know This Week
Welcome to The Psychedelic Blog. Bestselling essayist & Psychedelic cultural analyst examining how altered states sha...
Orchidaceaen Ethics 1
On acid, ancient philosophy, and the problem of knowing